Title:
IL13に対するヒト抗体および治療的使用
Document Type and Number:
Japanese Patent JP5006330
Kind Code:
B2
Abstract:
The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-tL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
More Like This:
Inventors:
Emma Michelle Campbell
Sophia Perbean
Joe Bueckler
Gunner's Bulkers
Sophia Perbean
Joe Bueckler
Gunner's Bulkers
Application Number:
JP2008535972A
Publication Date:
August 22, 2012
Filing Date:
October 19, 2006
Export Citation:
Assignee:
Novartis Age
International Classes:
C07K16/24; A61K38/16; A61K39/395; A61P1/04; A61P11/02; A61P11/06; A61P17/00; A61P29/00; A61P35/00; A61P35/02; A61P37/08; C12N15/09; C12P21/08
Foreign References:
| WO2005007699A1 | ||||
| WO2005091853A1 |
Other References:
Clin. Exp. Allergy,2005年 8月,Vol.35,pp.1096-1103
Attorney, Agent or Firm:
Mitsuo Tanaka
Hiroshi Yamazaki
Kenji Tomita
Mina Shiga
Hiroshi Yamazaki
Kenji Tomita
Mina Shiga